Skip to main content
. 2025 Feb 15;15(2):487–500. doi: 10.62347/QCCZ2316

Table 2.

Echocardiography measurements

Pre-Breast Cancer Post-Breast Cancer
(n = 8) (n = 8)
LVIDd, cm 0.67 ± 0.01 0.63 ± 0.03
LVIDs, cm 0.36 ± 0.01 0.33 ± 0.02
LVPWd, cm 0.18 ± 0.10 0.18 ± 0.02
LVPWs, cm 0.28 ± 0.01 0.31 ± 0.09
FS, % 46 ± 1 54 ± 4
LVEDV, ml 0.67 ± 0.05 0.60 ± 0.07
LVESV, ml 0.12 ± 0.01 0.10 ± 0.03
SV, ml 0.55 ± 0.04 0.52 ± 0.05
EF, % 82 ± 1 87 ± 3
Heart rate (bpm) 304 ± 6 314 ± 12
Cardiac output (mL/min) 167 ± 12 163 ± 17
LV ΔPT (mmHg/s) 8024 ± 191 ¥ 8585 ± 717
LVEDP (mmHg) 2 ± 0 ¥ 5 ± 1*

Data are means ± SE. n, number of rats; LV, left ventricular; LVIDd, LV internal diameter in diastole; LVIDs, LV internal diameter in systole; LVPWd, LV posterior wall in diastole; LVPWs, LV posterior wall in systole; FS, fractional shortening; LVEDV, LV end diastolic volume; LVESV, LV end systolic volume; SV, stroke volume; EF, ejection fraction; bpm, beats per minute; LV ΔP/ΔT, LV change in pressure over change in time; LVEDP, LV end diastolic pressure;

*

P < 0.05 vs pre-breast cancer;

¥

measured from subsample of healthy control rats (n = 5).